HIGHLIGHTS
- who: Jonathan Benzaquen and collaborators from the Department of Pulmonary Medicine and Oncology, Université Côte d'Azur, CHU de Nice, FHU OncoAge, FHU OncoAge, CHU de Nice, Nice, France have published the paper: Lung Cancer Screening towards Multidimensional Approach: Why and How?, in the Journal: Cancers 2018, 10, x FOR PEER REVIEW of /2018/
- what: It can be reasonably assumed that very soon, European health authorities will provide coverage for LDCT-based LCS.
SUMMARY
Lung cancer (LC) is the leading cause of death from cancer, but early-stage treatment improves . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.